Redsense Medical AB (publ)
RDSNF
$0.51
-$0.54-51.43%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -295.50K | 521.80K | -314.10K | 58.50K | -254.00K |
| Total Depreciation and Amortization | 1.50K | 1.60K | 1.60K | 1.60K | 1.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 95.20K | -98.80K | 62.20K | -10.00K | -53.80K |
| Change in Net Operating Assets | 270.20K | -490.50K | 294.80K | -499.90K | 1.10K |
| Cash from Operations | 71.30K | -66.00K | 44.60K | -449.80K | -305.20K |
| Capital Expenditure | -- | 0.00 | -- | -1.60K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -9.80K | 0.00 | -- | -53.40K | -2.20K |
| Cash from Investing | -9.80K | 0.00 | -- | -55.00K | -2.20K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 0.00 | 7.49M | 9.74M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 0.00 | 719.00K | 911.20K | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -100.00 | -- | -- | -- | -- |
| Net Change in Cash | 61.40K | -66.00K | 763.60K | 406.40K | -307.40K |